Prior Stephen David

Chief Strategy Officer at ANTX

Sold, on record
$10k
Dollars the filings state
Form 4 sales
3
Latest Jan 6, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ANTXAN2 Therapeutics, Inc.Chief Strategy Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ANTXNo plan
    Jan 3, 2025 2025

    Sold 2,029 shares at $1.34 ($3k)

    Prior Stephen David, Chief Strategy Officer

    No 10b5-1 planSold 5.7% of holdings ($47k position)33,313 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ANTXNo plan
    Nov 4, 2025 +305 days

    Sold 765 shares at $1.14 ($872)

    Prior Stephen David, Chief Strategy Officer

    No 10b5-1 planSold 1.2% of holdings ($76k position)65,548 shares leftFiling

  3. 3 Form 4 sale ANTXNo plan
    Jan 6, 2026 +63 days

    Sold 6,462 shares at $1.00 ($6k)

    Prior Stephen David, Chief Strategy Officer

    No 10b5-1 planSold 9.9% of holdings ($66k position)59,086 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Prior Stephen David
Source
Jan 6, 2026Jan 7, 2026ANTXChief Strategy OfficerForm 4 sale6,462$6k9.9%No planSEC
Nov 4, 2025Nov 6, 2025ANTXChief Strategy OfficerForm 4 sale765$8721.2%No planSEC
Jan 3, 2025Jan 7, 2025ANTXChief Strategy OfficerForm 4 sale2,029$3k5.7%No planSEC